Xtant Medical Holdings Inc (FRA:XMS)
€ 0.338 0 (0%) Market Cap: 53.71 Mil Enterprise Value: 81.86 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 41/100

Q1 2022 Xtant Medical Holdings Inc Earnings Call Transcript

May 05, 2022 / 01:00PM GMT
Release Date Price: €0.585 (-3.31%)
Operator

Greetings, and welcome to the Xtant Medical First Quarter 2022 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Matt Steinberg of Finn Partners. Please go ahead.

Matt Steinberg
Lazar Partners Ltd. - VP

Thank you, operator, and welcome to Xtant Medical's First Quarter 2022 Financial Results Call. Joining me today is Sean Browne, President and Chief Executive Officer; and Scott Neils, Interim Chief Financial Officer. Today's call is being webcast and will be posted on the company's website for playback.

During the course of this call, management may make certain forward-looking statements regarding future events and the company's expected future performance. These forward-looking statements reflect Xtant's current perspective on existing trends and information and can be identified by such words as expect, plan, will, may, anticipate, believe, should, intends and other words with similar meaning.

Such forward-looking statements are not

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot